(Q73101466)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Synergy between an antibody and CD8+ cells in eliminating an established tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Dyall R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Clynes RA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Ravetch JV

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Nikolić-Zugic J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

374-382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Anti-tumor immune responses of the tumor-bearing host: the case for antibody-mediated immunologic enhancement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Screening mouse mutations for resistance to cancer metastasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Mice lacking MHC class II molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

FcR gamma chain deletion results in pleiotrophic effector cell defects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Exact prediction of a natural T cell epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

The majority of postselection CD4+ single-positive thymocytes requires the thymus to produce long-lived, functional T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

CD4-independent in vivo priming of murine CTL by optimal MHC class I-restricted peptides derived from intracellular pathogens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

CD4 engagement induces Fas antigen-dependent apoptosis of T cellsin vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270206

7 January 2021

Identifiers

DOI

10.1002/EJI.1830270206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9045907%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference